Ionis Pharmaceuticals stockIONS
Ionis Pharmaceuticals trades at $38.80, 55.3% below its 52-week high (Feb 5, 2026). The price is below its 50- and 200-day averages, a downtrend. −51.0% year to date, −48.0% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 9, 2026.
Ratings, candles, signals and the screener for IONS — after you log in
Open the terminalFrequently asked questions about Ionis Pharmaceuticals
What is the Ionis Pharmaceuticals stock price?
At the close on Nov 5, 2026: $38.80 (−3.36% on the day). 52-week high: $86.74 on Feb 5, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Ionis Pharmaceuticals report earnings?
The next quarterly report is on Nov 9, 2026. Last quarter, earnings per share changed −199% year over year, revenue −41%.
Does Ionis Pharmaceuticals pay dividends?
No, Ionis Pharmaceuticals does not pay dividends.
Where does Ionis Pharmaceuticals trade and how to buy it?
Ticker IONS, exchange Nasdaq, listed since 1991. You can buy it through a broker with access to US exchanges.
Should I buy Ionis Pharmaceuticals now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for IONS are in the terminal after you log in.